We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Eleven Biotherapeutics Signs $270M Deal with Roche

News   Aug 17, 2016

 
Eleven Biotherapeutics Signs $270M Deal with Roche
 
 
 

RELATED ARTICLES

Viral Immunity Discovery Could Improve Vaccine Design

News

A molecular switch has been identified that impacts immune responses to viral infections, and whether or not protective antibodies are produced.

READ MORE

World First: Phase 1 Trial of Chlamydia Vaccine Finds That It Is Safe and Provokes Immune Response

News

The first ever chlamydia vaccine to reach phase 1 clinical trial has been found to be safe and able to provoke an immune response, according to a new study.

READ MORE

Natural Killer Cells May Help Women Avoid Deadly Risk of Childbirth

News

In one in every 272 births, the placenta becomes too deeply attached and removal can cause massive bleeding. Now researchers have found an important role for natural killer cells in preventing this happening.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE